153 related articles for article (PubMed ID: 20483887)
21. Clinical trials of botulinum toxin in the treatment of spasticity.
Simpson DM
Muscle Nerve Suppl; 1997; 6():S169-75. PubMed ID: 9826988
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
[TBL] [Abstract][Full Text] [Related]
23. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
Suputtitada A; Suwanwela NC
Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
[TBL] [Abstract][Full Text] [Related]
24. Does the use of a constraint mitten to encourage use of the hemiplegic upper limb improve arm function in adults with subacute stroke?
Burns A; Burridge J; Pickering R
Clin Rehabil; 2007 Oct; 21(10):895-904. PubMed ID: 17981848
[TBL] [Abstract][Full Text] [Related]
25. Botulinum treatment for post-stroke spasticity: low dose regime.
Viriyavejakul A; Vachalathiti R; Poungvarin N
J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
[TBL] [Abstract][Full Text] [Related]
26. Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS).
Málly J; Dinya E
Brain Res Bull; 2008 Jul; 76(4):388-95. PubMed ID: 18502315
[TBL] [Abstract][Full Text] [Related]
27. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
28. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
29. Use of botulinum toxin in stroke patients with severe upper limb spasticity.
Bhakta BB; Cozens JA; Bamford JM; Chamberlain MA
J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):30-5. PubMed ID: 8676154
[TBL] [Abstract][Full Text] [Related]
30. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
31. Can surface neuromuscular electrical stimulation of the wrist and hand combined with routine therapy facilitate recovery of arm function in patients with stroke?
Rosewilliam S; Malhotra S; Roffe C; Jones P; Pandyan AD
Arch Phys Med Rehabil; 2012 Oct; 93(10):1715-21.e1. PubMed ID: 22676906
[TBL] [Abstract][Full Text] [Related]
32. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
Restemeyer C; Weiller C; Liepert J
Restor Neurol Neurosci; 2007; 25(2):143-50. PubMed ID: 17726273
[TBL] [Abstract][Full Text] [Related]
33. Treatment with botulinum toxin type B for upper-limb spasticity.
Brashear A; McAfee AL; Kuhn ER; Ambrosius WT
Arch Phys Med Rehabil; 2003 Jan; 84(1):103-7. PubMed ID: 12589629
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury.
Verplancke D; Snape S; Salisbury CF; Jones PW; Ward AB
Clin Rehabil; 2005 Mar; 19(2):117-25. PubMed ID: 15759526
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
Brashear A; McAfee AL; Kuhn ER; Fyffe J
Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
Ashford S; Turner-Stokes L
Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
[TBL] [Abstract][Full Text] [Related]
37. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
Bhakta BB; Cozens JA; Chamberlain MA; Bamford JM
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
[TBL] [Abstract][Full Text] [Related]
38. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
39. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
Teasell R; Foley N; Pereira S; Sequeira K; Miller T
Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
